$CYBR Guidance: "For the fourth quarter of 2024, we expect total revenue of $297 million to $303 million, which represents 34% year-on-year growth at the midpoint, and that includes approximately $41 million from Venafi. We expect non-GAAP operating income in the range of $43.5… https://t.co/5ahE3ZJG8M
$CYBR (+6.4% pre) CyberArk beats top-line and bottom-line estimates; initiates Q4 and raises FY24 outlook - SA https://t.co/zVrM9Epfli
CyberArk shares up 8.32% premarket after strong Q3 results. $ARR $CYBR



Cronos Group reported its third-quarter results for 2024, revealing a net revenue increase of 38% year-over-year, totaling $34.3 million. However, the gross profit for the quarter was $3.6 million, which reflects a decrease of $0.4 million compared to the same period in 2023. This decline was attributed to the impact of inventory-related purchases on the cost of sales. In a separate report, CyberArk announced its third-quarter earnings, with total revenue reaching $240.1 million, marking a 26% increase from $191.2 million in the third quarter of 2023. The company achieved a GAAP net income of $11.1 million, or $0.24 per diluted share, a significant turnaround from a GAAP net loss of $14.6 million, or $(0.35) per basic share, in the prior year. Following the announcement, CyberArk shares rose by 8.32% in premarket trading. The company also provided guidance for the fourth quarter, expecting total revenue between $297 million and $303 million, which represents a 34% year-on-year growth at the midpoint, including approximately $41 million from Venafi.